Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial.

Carmen Hernandez-Cardenas,Ireri Thirion-Romero,Sebastián Rodríguez-Llamazares,Norma E Rivera-Martinez,Patricia Meza-Meneses,Arantxa Remigio-Luna,Rogelio Perez-Padilla

PloS one（2021）

引用 15|浏览8

暂无评分

摘要

No beneficial effect or significant harm could be demonstrated in our randomized controlled trial including 214 patients, using relatively low doses of Hydroxychloroquine compared with placebo in hospitalized patients with severe COVID-19.

查看译文

关键词

severe respiratory infection,treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要